The Data Activation Company, Innovaccer, Launches InAPI - Healthcare’s Most Advanced API Product to Exchange Healthcare Data
There are over 200 EHRs in the US healthcare space, thousands of exchange mechanisms, and billions of patient records spread across multiple disparate systems, and healthcare executives are finding it hard to make sense out of it. Providers, payers, and vendors are still struggling to go beyond the data they usually collect, and more often than not, patients cannot access their data.
In order to eliminate such complications, Innovaccer Inc., the leading healthcare data activation company, today announced the launch of InAPI - healthcare’s most advanced API specifically designed to power innovation with access to comprehensive, reliable, and high-quality healthcare data for providers, payers, and vendors.
InAPI is an off-the-shelf interfacing engine built on top of healthcare’s most advanced data activation platform. The platform aims at providing simplified data integration across the healthcare space with its 200+ pre-built connectors to multiple IT vendors and data sources. InAPI provides a simplified interfacing mechanism with just a click and is purpose-built for bidirectional interoperability, helping organizations power data-driven transformation.
“InAPI is the answer to every question that has been troubling healthcare for a long time now. With InAPI, organizations can leverage APIs to exchange data, power applications, and stay connected like never before. Finally, the data will be accessible, wherever we want, whenever we want, and however we want it— the way it is meant to be.” says Paul Grundy MD, MPH, FACOEM, FACPM, Chief Transformation Officer at Innovaccer.
From demographics to measures and attributes, the product provides APIs from its vast library of APIs to support any operation. The platform’s sophisticated algorithms normalize and map data into a standardized schema, providing users with a master patient index and error-free records. The standardized records can further be leveraged for various care initiatives such as care management and population health management, among others.
InAPI supports over 15 data formats providing connectors to over 500 healthcare IT vendors. With such infrastructure, InAPI can support HL7, CCDA, RDBMS, CSV, and X12 files for extraction of crucial data and aggregation into a standardized format. InAPI is FHIR-ready and ensures real-time data exchange. It is a REST API that provides comprehensive health data in a JSON format. The HIPAA-compliant and HITRUST-certified mechanisms ensure the security of ePHI. The platform also supports simplified data export to HL7 and CCDA documents and ensures easy SQL-based querying for quicker access to integrated records.
The solid data foundation of InAPI allows providers, payers, and vendors to power up applications that open up a variety of opportunities across chart retrievals, patient engagement, decision support, and BI. InAPI verifies data transformations and identifies broken ones, null values, and gaps in records to weed out bad data.
InAPI supports the use of visual ETL pipelines that eliminates the need for writing even a single line of code. It can integrate data to ensure easy chart retrievals, providing decision support for leaders and executives and the ability to get a clear picture of gaps in care, among many. It also monitors the usage of APIs across the network and control traffic effectively. Users get secure access to APIs because of InAPI’s access token and notification management that developers are already familiar with.
“Healthcare has been struggling to achieve true interoperability, and even after all these years, the dream of easily accessible data is still far from realization,” says Abhinav Shashank, CEO at Innovaccer. “InAPI is built to break this wheel of data fragmentation and disconnect. It is a foundational element to right the wrongs of healthcare technology and build healthcare’s information superhighway ”
Innovaccer Inc. is a leading healthcare data activation company committed to making a powerful and enduring difference in the way care is delivered. Innovaccer's aim is to make full use of all the data healthcare has worked so hard to collect by righting the wrongs of healthcare technology, doing away with long-standing problems and replacing them with ideal solutions. Its Gartner and KLAS-recognized products have been deployed all over the US across more than 500 locations, enabling over 10,000 providers to transform care delivery and work as one. Innovaccer's solutions have successfully activated data for several institutions, governmental organizations, and several corporate enterprises such as Mercy ACO, StratiFi Health, UniNet Healthcare Network, Catalyst Health Network, Hartford Healthcare, and Osler Health Network. Innovaccer is based in San Francisco and has offices all over the United States and Asia.
Suite 1829, Floor 18th, 535 Mission St, CA 94105
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Data Activation Company, Innovaccer, Launches InAPI - Healthcare’s Most Advanced API Product to Exchange Healthcare Data here
News-ID: 1763022 • Views: 280
More Releases from Innovaccer Inc.
Innovaccer Launches its Care Management Solution on Microsoft Teams Platform
Even after investing millions of dollars in making the care management process more efficient and seamless, provider care teams still find it difficult to work in collaboration. The challenge is not just in having all the necessary patient data, but limited connectivity is forcing care teams to continue to work in silos. What care teams need now is to access the right data at the right time. They need the
Innovaccer Launches Its Web Interface Reporting Solution to Help Providers Overc …
Amid healthcare’s rapid transformation to value-based care, measuring the quality of care is crucial. However, the short time frame for reporting, the exhaustive list of patient records and the manual intensive reporting process can seem a bit overwhelming to the providers. Providers need a solution that simplifies the quality reporting process and leaves them with more time to actually focus on the quality of care. Innovaccer Inc., the leading San Francisco-based
The Leading Data Activation Company, Innovaccer Launches Its Solution for Seamle …
Even after years of investing in value-based care, healthcare still lacks defined communication channels to connect providers and patients. Organizations still operate in silos which often limits their operational efficiency. From scheduling patient appointments to reporting on patients’ health conditions, the US healthcare system needs a presto chango at multiple fronts. According to a report added on the ‘Research and Markets’ website, the global referral management market is expected to
Innovaccer, the Leading Data Activation Company, Strengthens its Solution for Me …
The CMS has projected that Medicare Advantage enrollment will reach an "all-time high" in 2019 with 22.6 million Medicare beneficiaries, given the unprecedented growth. Medicare Advantage plans are one of the frontline players in the push for value-based care and need to gear up to achieve an excellent care ecosystem for their members with the best clinical and financial outcomes. In order to achieve this goal, Medicare Advantage plans require complete
More Releases for API
Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles. Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform. Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Global Biotech API Market Analysis
RNCOS has recently added a new Market Research Report titled, “Global Biotech API Market Analysis” to its report gallery. Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly prospective market in the future. As per our